Related Experiment Video

Updated: Aug 17, 2026

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
07:40

Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis

Published on: March 20, 2021

Potential clinical impact of taking multiple blood samples for research studies in paediatric oncology: how much do

Michael Cole1, Alan V Boddy, Pamela Kearns

  • 1Northern Institute for Cancer Research, University of Newcastle upon Tyne, Newcastle upon Tyne, United Kingdom.

Pediatric Blood & Cancer
|July 12, 2005
PubMed

Insights

Pediatric cancer drug studies need careful blood sample management. Research should prioritize essential scientific questions and minimize blood draws to ensure patient safety and ethical research practices.

Area of Science:

  • Pediatric Oncology
  • Clinical Pharmacology
  • Biomedical Research Ethics

Background:

  • Clinical pharmacology studies of anti-cancer agents in children are crucial due to potential differences in safety and efficacy compared to adults.
  • Concerns exist regarding the clinical impact of additional blood sampling for research in pediatric cancer patients, affecting both healthcare staff and parents.
  • Existing 'safe limits' for blood volume withdrawal (3%-5%) lack empirical data and may not be universally applicable.

Purpose of the Study:

  • To review reasons for the scarcity of pediatric anti-cancer drug pharmacology data.
  • To summarize findings from a retrospective study on the impact of repeated blood sampling for research.
  • To propose systematic approaches for addressing blood sampling issues in future pediatric oncology research.

Main Methods:

  • Literature review on challenges in pediatric clinical pharmacology research.
  • Retrospective analysis of data concerning repeated blood sampling in pediatric cancer patients for research.
  • Discussion of strategies for optimizing blood sample collection in pediatric research.

Main Results:

  • Clinical pharmacology data for pediatric anti-cancer drugs is often limited.
  • A retrospective study investigated the impact of research-related blood sampling.
  • The review highlights the need for evidence-based guidelines on blood sampling in pediatric research.

Conclusions:

  • Future research involving pediatric cancer patients must address critical scientific questions.
  • Study designs should minimize the number and volume of blood samples required.
  • Ethical considerations and patient well-being are paramount in pediatric oncology research design.

More Related Videos

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 105:44

Concurrent Collection of Fetal Murine Brain and Serum to Assess Effects of Maternal Diet on Nutrition and Neurodevelopment in Neurofibromatosis Type 1

Published on: May 17, 2024

Related Concept Videos

Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...